Bennett C Frank
Officer at IONS
- Sold, on record
- $39M
- Dollars the filings state
- Form 4 sales
- 71
- Latest Jul 7, 2026
- Form 144 notices
- 14
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- IONSIONIS PHARMACEUTICALS INCOfficer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale IONSNo planJan 16, 2026 2026
Sold 8,977 shares at $75.15 ($675k)
Bennett C Frank, EVP, Chief Scientific Officer
No 10b5-1 planSold 8.7% of holdings ($7.8M position)94,757 shares left1.3x usual sizeFollows a Form 144Filing
- 2 Form 144 notice IONSNoticeJan 30, 2026 +14 days
Filed to sell 5,885 shares ($488k)
Bennett C Frank, Officer
No 10b5-1 plan0.9x usual sizeFiling
- 3 Form 4 sale IONSNo planJan 30, 2026 same day
Sold 5,885 shares at $82.95 ($488k)
Bennett C Frank, EVP, Chief Scientific Officer
No 10b5-1 planSold 5.5% of holdings ($8.8M position)100,293 shares left0.9x usual sizeFollows a Form 144Filing
- 4 Form 144 notice IONSNoticeFeb 2, 2026 +3 days
Filed to sell 85,089 shares ($7.1M)
Bennett C Frank, Officer
10b5-1 plan12.6x usual sizeFiling
- 5 Form 4 sale IONSUnusualFeb 2, 2026 same day
Sold 85,089 shares at $82.93 ($7.1M)
Bennett C Frank, EVP, Chief Scientific Officer
10b5-1 planSold 51.4% of holdings ($13.7M position)80,293 shares left12.6x usual sizeFollows a Form 144Filing
- 6 Form 4 sale IONSUnusualMar 3, 2026 +29 days
Sold 85,089 shares at $79.23 ($6.7M)
Bennett C Frank, EVP, Chief Scientific Officer
10b5-1 planSold 51.4% of holdings ($13.1M position)80,554 shares left10.8x usual sizeFiling
- 7 Form 144 notice IONSNoticeJul 7, 2026 +126 days
Filed to sell 67,386 shares ($5.7M)
Bennett C Frank, Officer
10b5-1 plan7.5x usual sizeFiling
- 8 Form 4 sale IONSRoutineJul 7, 2026 same day
Sold 20,536 shares at $84.95 ($1.7M)
Bennett C Frank, EVP, Chief Scientific Officer
10b5-1 planSold 21.5% of holdings ($8.1M position)75,018 shares left2.3x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (85)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Jul 9, 2026 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 20,536 | $1.7M | 21.5% | Routine | SEC |
| Jul 7, 2026 | Jul 7, 2026 | IONS | Officer | Form 144 notice | 67,386 | $5.7M | Notice | SEC | |
| Mar 3, 2026 | Mar 5, 2026 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 85,089 | $6.7M | 51.4% | Unusual | SEC |
| Feb 2, 2026 | Feb 4, 2026 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 85,089 | $7.1M | 51.4% | Unusual | SEC |
| Feb 2, 2026 | Feb 2, 2026 | IONS | Officer | Form 144 notice | 85,089 | $7.1M | Notice | SEC | |
| Jan 30, 2026 | Feb 2, 2026 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 5,885 | $488k | 5.5% | No plan | SEC |
| Jan 30, 2026 | Jan 30, 2026 | IONS | Officer | Form 144 notice | 5,885 | $488k | Notice | SEC | |
| Jan 16, 2026 | Jan 20, 2026 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 8,977 | $675k | 8.7% | No plan | SEC |
| Jan 16, 2026 | Jan 16, 2026 | IONS | Officer | Form 144 notice | 8,977 | $684k | Notice | SEC | |
| Sep 5, 2025 | Sep 9, 2025 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 6,000 | $358k | 6.8% | Routine | SEC |
| Sep 3, 2025 | Sep 4, 2025 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 38,909 | $2.3M | 27.7% | Unusual | SEC |
| Sep 3, 2025 | Sep 3, 2025 | IONS | Officer | Form 144 notice | 51,800 | $3.2M | Notice | SEC | |
| Aug 18, 2025 | Aug 20, 2025 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 10,000 | $440k | 9.7% | Routine | SEC |
| Aug 18, 2025 | Aug 18, 2025 | IONS | Officer | Form 144 notice | 16,000 | $704k | Notice | SEC | |
| Jan 31, 2025 | Feb 3, 2025 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 1,327 | $43k | 1.4% | No plan | SEC |
| Jan 31, 2025 | Jan 31, 2025 | IONS | Officer | Form 144 notice | 1,803 | $63k | Notice | SEC | |
| Jan 16, 2025 | Jan 17, 2025 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 6,752 | $222k | 6.9% | No plan | SEC |
| Jan 16, 2025 | Jan 16, 2025 | IONS | Officer | Form 144 notice | 6,752 | $221k | Notice | SEC | |
| Feb 2, 2024 | Feb 2, 2024 | IONS | Officer | Form 144 notice | 1,853 | $92k | Notice | SEC | |
| Feb 2, 2024 | Feb 2, 2024 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 1,853 | $92k | 2.3% | No plan | SEC |
| Jan 17, 2024 | Jan 18, 2024 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 6,745 | $340k | 8.0% | No plan | SEC |
| Jan 17, 2024 | Jan 17, 2024 | IONS | Officer | Form 144 notice | 6,745 | $341k | Notice | SEC | |
| Dec 22, 2023 | Dec 22, 2023 | IONS | Officer | Form 144 notice | 22,613 | $1.1M | Notice | SEC | |
| Dec 21, 2023 | Dec 22, 2023 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 22,613 | $1.1M | 25.6% | Unusual | SEC |
| Dec 15, 2023 | Dec 15, 2023 | IONS | Officer | Form 144 notice | 22,612 | $1.1M | Notice | SEC | |
| Dec 14, 2023 | Dec 18, 2023 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 22,612 | $1.1M | 25.6% | Unusual | SEC |
| Sep 29, 2023 | Sep 29, 2023 | IONS | Officer | Form 144 notice | 4,460 | $207k | Notice | SEC | |
| Sep 28, 2023 | Sep 29, 2023 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 4,460 | $207k | 6.4% | Routine | SEC |
| Feb 6, 2023 | Feb 7, 2023 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 1,813 | $74k | 2.5% | Plan not stated | SEC |
| Feb 6, 2023 | Feb 6, 2023 | IONS | Officer | Form 144 notice | 1,813 | $74k | Notice | SEC | |
| Jan 18, 2023 | Jan 19, 2023 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 6,978 | $271k | 9.3% | Plan not stated | SEC |
| Dec 4, 2020 | Dec 8, 2020 | IONS | Chief Scientific Officer | Form 4 sale | 7,947 | $406k | 19.7% | Plan not stated | SEC |
| Dec 2, 2020 | Dec 4, 2020 | IONS | Chief Scientific Officer | Form 4 sale | 7,053 | $362k | 17.8% | Plan not stated | SEC |
| Nov 3, 2020 | Nov 5, 2020 | IONS | Chief Scientific Officer | Form 4 sale | 15,000 | $702k | 31.6% | Unusual | SEC |
| Jun 25, 2020 | Jun 29, 2020 | IONS | EVP, Chief Scientific Officer | Form 4 sale | 15,000 | $897k | 31.7% | Unusual | SEC |
| Feb 1, 2019 | Feb 5, 2019 | IONS | SVP, Antisense Research | Form 4 sale | 9,013 | $525k | 26.9% | Unusual | SEC |
| Nov 1, 2018 | Nov 1, 2018 | IONS | SVP, Antisense Research | Form 4 sale | 12,500 | $619k | 39.2% | Unusual | SEC |
| Aug 8, 2018 | Aug 9, 2018 | IONS | SVP, Antisense Research | Form 4 sale | 12,500 | $563k | 39.2% | Unusual | SEC |
| May 11, 2018 | May 11, 2018 | IONS | SVP, Antisense Research | Form 4 sale | 12,500 | $563k | 39.5% | Unusual | SEC |
| Jan 16, 2018 | Jan 17, 2018 | IONS | SVP, Antisense Research | Form 4 sale | 2,696 | $140k | 12.4% | Plan not stated | SEC |
| Oct 18, 2017 | Oct 20, 2017 | IONS | SVP, Antisense Research | Form 4 sale | 12,250 | $796k | 44.9% | Unusual | SEC |
| Jul 24, 2017 | Jul 26, 2017 | IONS | SVP, Antisense Research | Form 4 sale | 10,000 | $593k | 39.9% | Unusual | SEC |
| Mar 3, 2017 | Mar 6, 2017 | IONS | SVP, Antisense Research | Form 4 sale | 5,000 | $275k | 25.3% | Unusual | SEC |
| Jan 17, 2017 | Jan 18, 2017 | IONS | SVP, Antisense Research | Form 4 sale | 2,421 | $112k | 14.1% | Plan not stated | SEC |
| Nov 9, 2016 | Nov 14, 2016 | IONS | SVP, Antisense Research | Form 4 sale | 22,805 | $857k | 67.9% | Unusual | SEC |
| Nov 7, 2016 | Nov 9, 2016 | IONS | SVP, Antisense Research | Form 4 sale | 5,000 | $170k | 31.6% | Unusual | SEC |
| Jan 19, 2016 | Jan 19, 2016 | IONS | SVP, Antisense Research | Form 4 sale | 2,110 | $87k | 16.6% | Plan not stated | SEC |
| Dec 16, 2015 | Dec 17, 2015 | IONS | SVP, Antisense Research | Form 4 sale | 7,909 | $454k | 51.9% | Unusual | SEC |
| Nov 10, 2015 | Nov 12, 2015 | IONS | SVP, Antisense Research | Form 4 sale | 5,000 | $320k | 40.6% | Unusual | SEC |
| Nov 6, 2015 | Nov 9, 2015 | IONS | SVP, Antisense Research | Form 4 sale | 5,000 | $280k | 40.6% | Unusual | SEC |